|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 244.80 ILa | -2.86% |
|
-2.00% | -24.35% |
| 04-30 | InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 03-03 | InterCure Receives Noncompliance Notice From Nasdaq | MT |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 186M | -9.55% | -5.9% | - | - | - | |
| 78.12M | 12.18% | 20.68% | - | - | - | |
| 501M | -23.61% | -3.4% | -661.87% | -8.62% | 1.85x | |
| 263M | -26.09% | 1.85% | - | -15.9% | 3.62x | |
| 51.37M | -35.03% | - | - | - | - | |
| Average | 216M | -16.42% | 3.31% | -661.87% | -12.26% | 2.73x | |
| Weighted average by Cap. | 225M | -13.04% | 2.36% | -661.87% | -11.99% | 2.67x |
- Stock Market
- Equities
- INCR Stock
- Sector InterCure Ltd.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition